Catalio has just raised over $400M to back biotech and medtech startups. What does that mean for hiring?
👉 https://t.co/RXW5RbbrQJ
#Biotech#LifeSciences#VentureCapital
Regeneron has agreed to acquire the embattled genetics company 23andMe for $256M through a court-supervised sale. The deal strengthens Regeneron’s genomics-driven drug discovery work while promising safeguards for 23andMe’s customer data.
☕ The countdown is on — QC and Coffee launches in 1 week!
Hosted by Tiahti Young of LifeTech Staffing, we’re serving up real stories and career insights from the life sciences world.
🎧 Episode 1 drops May 12. Don’t miss it.
#QCandCoffee#PodcastLaunch#LifeSciences
☕ Introducing QC and Coffee — LifeTech Staffing's new podcast for the life sciences world!
Hosted by Tiahti Young, we’re brewing real convos about career journeys, industry shifts, and growth. No sugar-coating.
First episode drops May 12!
#QCandCoffee#LifeSciences#Podcast
Eli Lilly may be on the verge of a major medical breakthrough. In a recent trial, its new drug, lepodisiran, reduced a genetic heart disease risk factor by a staggering 94%.
Read the full story at https://t.co/JzgUzGLlQc
Despite a judge's pause, NIH’s proposed 15% cap on indirect cost reimbursements faces legal battles. Universities warn cuts could stifle innovation—UPenn alone risks a $240M annual loss. A key Feb. 21 hearing may extend the halt, but uncertainty looms. #ResearchFunding#NIH
In 2024, healthcare venture capital funding in the U.S. surged to $23 billion, up from $20 billion in 2023, with artificial intelligence (AI) startups leading the charge.
Read more at: https://t.co/cB6LjJTV5t
With a focus on neuropsychiatry, Seaport aims to build on Karuna's success in addressing unmet needs in psychiatric care. 🌱💡#Biotech#MentalHealth#Neuropsychiatry#VentureCapital
Source: https://t.co/FVIeCFwpZ3
Setbacks like these can increase demand for clinical trial experts, regulatory specialists, and R&D roles—areas where LifeTech Staffing can connect talent with evolving industry needs. #Biotech#Staffing
https://t.co/D82MJh0uSQ
At LifeTech Staffing, we believe the value of a placement isn’t just in finding the right talent—it’s in ensuring they stay long-term. That’s why we work overtime to ensure you are connected to the perfect position at the right company.
(Source: ApolloTechnical, 2024)
Bristol Myers Squibb's $14 billion acquisition of Karuna Therapeutics has led to the FDA approval of Cobenfy, a novel schizophrenia drug with fewer side effects, marking a significant step in addressing treatment gaps.
#Neurology#Biotech
Source: https://t.co/2FnbJzPOCy
AstraZeneca's FluMist is now the first FDA-approved self-administered flu vaccine, offering a more convenient option for flu prevention.
#FluMist#FDAApproved#HealthcareInnovation
Eli Lilly has released single-dose vials of its obesity drug Zepbound, offering a more affordable self-pay option that could help address previous supply issues and provide an alternative to compounded versions.
Read more: https://t.co/CEevivpxBB
#PharmaNews#HealthcareInnovation